The importance of international collaboration for rare diseases research: a European perspective

Autor: Julkowska, D, Austin, C P, Cutillo, C M, Gancberg, D, Hager, C, Halftermeyer, J, Jonker, A H, Lau, L P L, Norstedt, I, Rath, A, Schuster, R, Simelyte, E, van Weely, S

Publikováno v: Gene Therapy

Over the last two decades, important contributions were made at national, European and international levels to foster collaboration into rare diseases research. The European Union (EU) has put much effort into funding rare diseases research, encourag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::237c99280531cd3fb6e70780e70247a7
http://europepmc.org/articles/PMC5628265

COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in Europe.

Autor: Depoortere E; Directorate-General for Research and Innovation, European Commission, Brussels, Belgium. Electronic address: evelyn.depoortere@ec.europa.eu., Sowinski S; Directorate-General for Research and Innovation, European Commission, Brussels, Belgium., van Hengel A; Directorate-General for Research and Innovation, European Commission, Brussels, Belgium., Kerstiëns B; Directorate-General for Research and Innovation, European Commission, Brussels, Belgium., Norstedt I; Directorate-General for Research and Innovation, European Commission, Brussels, Belgium.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Mar; Vol. 22 (3), pp. 315.

Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.

Autor: Austin CP; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Cutillo CM; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Lau LPL; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France., Jonker AH; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France., Rath A; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France.; Orphanet, Inserm-US14, Rare Diseases Platform, Paris, France., Julkowska D; Agence Nationale de la Recherche (ANR), Paris, France., Thomson D; Shire, Lexington, Massachusetts, USA, (until April 2017)., Terry SF; Genetic Alliance, Washington DC, USA., de Montleau B; EURORDIS-Rare Diseases Europe, Paris, France., Ardigò D; Corporate Drug Development, Chiesi Farmaceutici S.p.A., Italy., Hivert V; EURORDIS-Rare Diseases Europe, Paris, France., Boycott KM; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada., Baynam G; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.; Western Australian Register of Developmental Anomalies, Perth, Australia., Kaufmann P; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Taruscio D; National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy., Lochmüller H; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK., Suematsu M; Japan Agency for Medical Research and Development (AMED), Tokyo, Japan., Incerti C; Sanofi Genzyme, Cambridge, Massachusetts, USA., Draghia-Akli R; Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017).; Merck & Co. Inc., Upper Gwynedd, Pennsylvania, USA, (from June 2017)., Norstedt I; Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017)., Wang L; National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), Bethesda, Maryland, USA., Dawkins HJS; Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia, Perth, Australia.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2018 Jan; Vol. 11 (1), pp. 21-27. Date of Electronic Publication: 2017 Oct 23.

Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease.

Autor: Nobes, Jennifer^1,2 (AUTHOR), Leith, Damien^3,4 (AUTHOR), Handjiev, Sava^1,4 (AUTHOR), Dillon, John F.^3,4 (AUTHOR), Dow, Ellie¹ (AUTHOR) ellie.dow2@nhs.scot

Publikováno v: Diagnostics (2075-4418). May2024, Vol. 14 Issue 9, p960. 15p.

Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.

Autor: Marques, Lara^1,2,3 (AUTHOR) lara.marques2010@hotmail.com, Costa, Bárbara^1,2,3 (AUTHOR) b.c.211297@gmail.com, Pereira, Mariana^1,2,4 (AUTHOR) mariana.m.pereira2097@gmail.com, Silva, Abigail^1,2,5 (AUTHOR) abigailsilva@outlook.pt, Santos, Joana^1,2,3 (AUTHOR) jmdmsantos@hotmail.com, Saldanha, Leonor^1,2,3 (AUTHOR) leonorpessanha@gmail.com, Silva, Isabel^1,2,3 (AUTHOR) iumsmed@gmail.com, Magalhães, Paulo⁶ (AUTHOR) paulo.r.magalhaes1@gmail.com, Schmidt, Stephan⁷ (AUTHOR) sschmidt@cop.ufl.edu, Vale, Nuno^1,2,3 (AUTHOR) nunovale@med.up.pt

Publikováno v: Pharmaceutics. Mar2024, Vol. 16 Issue 3, p332. 39p.